인쇄하기
취소

Biotech products development·efficacy equivalence test concentration

Published: 2001-06-05 06:58:00
Updated: 2001-06-05 06:58:00
The Korea Food and Drug Administration (KFDA) plans to make a concentrated investment in development of biotechnology products and their safety management·efficacy equivalence test management next year.

KFDA settled a draft budget of next year, which was increased to 171,339 million won by 138.7% from this year, and submitted the bill to the Planning and Budget Agency.

KFDA largely increa...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.